| Name | Title | Contact Details |
|---|
A BROKER DEALER BUILT AROUND THE NEEDS OF THE TRUSTED, INDEPENDENT ADVISOR
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Chi5 Consulting is a Chicago, IL-based company in the Software and Internet sector.
Automated Internet Technologies is a Huntington Beach, CA-based company in the Software and Internet sector.
VertexOne, the first cloud CIS & customer experience management platform for utility companies. A world class, affordable platform for utilities of all sizes.